Literature DB >> 18474455

Exploring skin structure using cryo-electron microscopy and tomography.

Lars Norlen1.   

Abstract

The lack of a molecular understanding, at the nanometer level, of skin biology represents one major obstacle towards the advancement of dermatology. High-resolution cryo-transmission electron microscopy (CEMOVIS) and tomography (CETOVIS) of vitreous skin sections can, however, be used to visualize the native molecular organisation of skin. Micrographs obtained by CEMOVIS show more detail and sometimes differ dramatically from those obtained by conventional methods. Further, molecular resolution (1.5-5 nm) 3D reconstructions of skin can be obtained when CEMOVIS is combined with tomography. In vitreous sections the native organization of skin may be preserved down to atomic resolution. CEMOVIS and CETOVIS are consequently ideally suited for molecular skin research.

Mesh:

Substances:

Year:  2008        PMID: 18474455     DOI: 10.1684/ejd.2008.0387

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

1.  Towards native-state imaging in biological context in the electron microscope.

Authors:  Anne E Weston; Hannah E J Armer; Lucy M Collinson
Journal:  J Chem Biol       Date:  2009-11-15

2.  Mathematical modeling of the impact of actin and keratin filaments on keratinocyte cell spreading.

Authors:  Jin Seob Kim; Chang-Hun Lee; Baogen Y Su; Pierre A Coulombe
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

3.  Platelet lysate can support the development of a 3D-engineered skin for clinical application.

Authors:  I Banakh; Md M Rahman; C L Arellano; D C Marks; S Mukherjee; C E Gargett; H Cleland; S Akbarzadeh
Journal:  Cell Tissue Res       Date:  2022-10-22       Impact factor: 4.051

4.  Self-consistent field theory for the interactions between keratin intermediate filaments.

Authors:  Anna Akinshina; Etienne Jambon-Puillet; Patrick B Warren; Massimo G Noro
Journal:  BMC Biophys       Date:  2013-09-05       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.